unresectable gallbladder carcinoma

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial

Not yet recruiting
  • Recurrent Biliary Tract Carcinoma
  • +13 more
  • (no location specified)
Nov 8, 2022

Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic

Active, not recruiting
  • Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
  • +27 more
  • Los Angeles, California
  • +2 more
Aug 5, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +15 more
  • Los Angeles, California
  • +1 more
Aug 5, 2022

Cholangiocarcinoma, Liver and Intrahepatic Bile Duct Carcinoma, Stage III Gallbladder Cancer AJCC v7 Trial in Houston

Completed
  • Cholangiocarcinoma
  • +11 more
  • Laboratory Biomarker Analysis
  • Ramucirumab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 7, 2022

Stage III Intrahepatic Cholangiocarcinoma AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7, Stage IIIB Gallbladder Cancer AJCC v7

Completed
  • Stage III Intrahepatic Cholangiocarcinoma AJCC v7
  • +8 more
  • Scottsdale, Arizona
  • +2 more
Jan 5, 2022

Stage III Distal Bile Duct Cancer AJCC v8, Stage III Gallbladder Cancer AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC

Active, not recruiting
  • Stage III Distal Bile Duct Cancer AJCC v8
  • +16 more
  • Anchorage, Alaska
  • +691 more
Oct 8, 2021

Advanced Adult Hepatocellular Carcinoma, Localized Non-Resectable Adult Liver Carcinoma, Recurrent Adult Liver Carcinoma Trial

Completed
  • Advanced Adult Hepatocellular Carcinoma
  • +7 more
  • Akt Inhibitor MK2206
  • +2 more
  • Los Angeles, California
  • +7 more
May 16, 2016